Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders

Dementia and Geriatric Cognitive Disorders

Volumn 10, Issue 2, 1999, Pages 158-165

  Aksenova, Marina V ^a   Aksenov, M Y ^b   Payne, R M ^d   Trojanowski, J Q ^c   Schmidt, M L ^c   Carney, J M ^e   Butterfield, D A ^a   Markesbery, W R ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e EVOTEC AG   (Germany)

Author keywords

Creatine kinase BB; Neurodegenerative disorders; Oxidative stress; Protein carbonyls

Indexed keywords

CARBONYL DERIVATIVE; CELL PROTEIN; CREATINE KINASE; CREATINE KINASE BB; ISOENZYME;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CELL DAMAGE; CONTROLLED STUDY; CYTOSOL; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DISEASE MARKER; FEMALE; FRONTAL CORTEX; FRONTAL LOBE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NIGRONEOSTRIATAL SYSTEM; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOTTING, WESTERN; CREATINE KINASE; CYTOSOL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FRONTAL LOBE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOENZYMES; MALE; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PARKINSON DISEASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0033014542     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017098     Document Type: Article

References (55)

1. Kuzuhara S, Yoshimura M: Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly. Adv Neurol 1993;60: 464-469.
2. Farina E, Cappa SF, Polimeni M, Magni E, Canesi M, Zecchinelli A, Scarlato G, Mariani C: Frontal dysfunction in early Parkinson's disease. Acta Neurol Scand 1994;90:34-38.
3. Cronin-Golomb A, Corkin S, Growdon JH: Visual dysfunction predicts cognitive deficits in Alzheimer's disease. Optom Vis Sci 1995;72: 168-176.
4. Jacobs D, Sano M, Marder K, Bell K: Age at onset of Alzheimer's disease: Relation to pattern of cognitive dysfunction and rate of decline. Neurology 1994;44:1215-1220.
5. Kesler A, Artzy T, Yaretzky A, Kott E: Slowly progressive aphasia, a left temporal variant of probable Pick's disease: 15 years of follow-up. Isr J Med Sci 1995;31:626-628.
6. Castellani R, Smith MA, Richey PL, Kalaria R, Gambetti P, Perry G: Evidence for oxidative stress in Pick disease and corticobasal degeneration. Brain Res 1995;696:268-271.
7. Beal MF: Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995; 38:357-366.
8. Bowling AC, Beal MF: Bioenergetic and oxidativc stress in neurodegenerative diseases. Life Sci 1995;56:1151-1171.
9. Jenner P: Oxidative damage in neurodegenerative disease. Lancet 1994;344:796-798.
10. Harman D: Free radical theory of aging: Alzheimer's disease pathogenesis. Age 1995;18: 97-119.
11. Gutteridge JM: Hydroxyl radicals, iron, oxidative stress, and neurodegeneration. Ann NY Acad Sci 1994;738:201-213.
12. Katzman R: Alzheimer's disease. N Engl J Med 1986;314:964-973.
13. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov MM, Gabbita P, Wu J. Carney J, Lowell M, Markesbery WR, Butterfield DA: Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 1995;65:2146-2156.
14. Hensley K, Butterfield DA, Hall N, Cole P, Subramaniam R, Mark R, Mattson MP, Markesbery WR, Harris ME, Aksenov M, Aksenova M, Wu JF, Carney JM: Reactive oxygen species as casual agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide. Ann NY Acad Sci 1996;786:120-134.
15. Butterfield DA: β-Amyloid-associated free radical oxidative stress and neurotoxicity: Implications for Alzheimer's disease. Chem Res Toxicol 1997;10:495-506.
16. Markesbery WR: Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1997;134-147.
17. Frolich L, Riederer P: Free radical mechanisms in dementia of Alzheimer's type and the potential for antioxidative treatment. Arzneimittelforschung 1995;45:443-446.
18. Zhou Y, Richardson JS, Mombouquette MJ, Weil JA: Free radical formation in autopsy of Alzheimer and control cortex. Neurosci Lett 1995;195:89-92.
19. Lippa CF, Smith TW, Swearer JM: Alzheimer's disease and Lewy body disease: A comparative clinicopathological study. Ann Neurol 1994;35:81-88.
20. De la Monte SM, Wands JR: Diagnostic utility of quantitating neurofilament-immunoreactive Alzheimer's disease lesions. J Histochem Cytochem 1994;42:1625-1634.
21. Hedera P, Lerner AJ, Castellani R, Friedland RP: Concurrence of Alzheimer's disease, Parkinson's disease, diffuse Lewy body disease, and myotrophic lateral sclerosis. J Ncurol Sci 1995;128:219-224.
22. Olichney JM, Galasko D, Corey-Bloom J, Thal LJ: The spectrum of diseases with diffuse Lewy bodies. Adv Neurol 1995;65:159-170.
23. Gotz ME, Kunig G, Riederer P, Youdim MB: Oxidative stress: Free radical production in neural degeneration. Pharmacol Ther 1994;63: 37-122.
24. Dalla Barbra G, Boller F: Non-Alzheimer degenerative dementias. Curr Opin Neurol 1994; 7:305-309.
25. Connor JR, Snyder BS, Arosio P, Loeffler DA, LeWitt P: A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J Neurochem 1995;65:717-724.
26. Aksenov MY, Aksenova MV, Payne RM, Smith CD, Markesbery WR, Carney JM: The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease. Exp Neurol 1997;146:458-465.
27. Bessman SP, Geiger PG: Transport of energy in muscle: The phosphorylcreatine shuttle. Science 1981;211:448-452.
28. Wallimann T, Schlosser T, Eppenberger HM: Function of M-line bound creatine kinase as intramyofibrillar ATP regenerator and the receiving end of the phosphorylcreatine shuttle in muscle. J Biol Chem 1984;259:5238-5246.
29. Wallimann T, Walzthony D, Wegmann G, Moser H, Eppenberger HM, Barrantes FJ: Subcellular localization of creatine kinase in Torpedo electrocytes: Association with acetylcholine receptor-rich membranes. J Cell Biol 1985; 100:1063-1072.
30. Thomas C, Carr AC, Winterbourn CC: Free radical inactivation of rabbit muscle creatine kinase: Catalysis by physiological and hydrolyzed ICRF-187 (ICRF-198) iron chelates. Free Radic Res 1994;21:387-397.
31. Banerjee A, Grosso MA, Brown JM, Rogers KB, Whitman GJR: Oxygen metabolite effects on creatine kinase and cardiac energetics after reperfusion. Am J Physiol 1991;261:H590-H597.
32. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
33. Khachaturian ZS: Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.
34. Mirra SS, Heyman A, McKeel D: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II: Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
35. Gibb WRG, Esiri MM, Lees AJ: Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 1987;110:1131-1153.
36. Dickson DW, Crystal H, Mattiace LA, Kress Y, Schwagerl A, Davies P, Yen S-H: Diffuse Lewy body disease: Light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol 1989;78:572-584.
37. Arai H, Schmidt ML, Lee VM-Y, Hurtig HI, Greenberg BD, Adler CH, Trojanowski JQ: Epitope analysis of senile plaque components in the hippocampus of patients with Parkinson's disease. Neurology 1992;42:1315-1322.
38. Cummings JL: The dementia of Parkinson's disease: Prevalence, characteristics, neurobiology, and comparison with dementia of the Alzheimer's type. Eur J Neurol 1988;28:15-23.
39. Trojanowski JQ, Lee VM-Y: Phosphorylation of neuronal cytoskeletal proteins in Alzheimer's disease and Lewy body dementias. Ann NY Acad Sci 1994;747:92-109.
40. Schmidt ML, Murray J, Lee VM-Y, Hill WD, Wertkin A, Trojanowski JQ: Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol 1991;139:53-66.
41. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
42. Glenney JR: Antibody probing on Western blots have been stained with India ink. Anal Biochem 1986;156:315-318.
43. Burbaeva GS, Aksenova MV, Makarenko IG: Decreased level of creatine kinase BB in the frontal cortex of Alzheimer patients. Dementia 1992;3:91-94.
44. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz A-G, Ahn B-W, Shaltiel S, Stadtman ER: Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990;186:464-487.
45. Levine RL, Williams JA, Stadtman ER, Shacter E: Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994;233:346-357.
46. Chromzynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
47. Manniatis T, Fritsch EF, Sambrook J: A Laboratory Manual: Molecular Cloning. New York, Cold Spring Harbor Laboratory, 1982.
48. Lennox G: Lewy body dementia; in Rossor MN (ed): Baillière's Clinical Neurology. London, Ballière Tindall, 1992, vol I: Unusual Dementias, pp 653-676.
49. De Vos RA, Jansen EN, Stam FC, Ravid R, Swaab DF: 'Lewy body disease': Clinico-pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia. Clin Neurol Neurosurg 1995;97:13-22.
50. Markesbery WR: Pick's disease: in Markesbery WR (ed): Neuropathology of Dementing Diseases. London, Arnold, 1998, pp 142-153.
51. Vonsattel JPG, Binetti G, Kelley LM: Pick's disease: in Wasco W, Tanzi RE (eds): Molecular Models of Dementia. Totowa, Humana Press, 1996, pp 253-269.
52. Lieffler DA, LeWitt PA, Juneau PL, Sima AAF, Nguyen H-U, DeMaggio AJ, Brickman CM, Brewer GJ, Dick RD, Troyer MD, Kanaley L: Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res 1996;738:265-274.
53. Youdim MB, Lavie L, Riederer P: Oxygen free radicals and neurodegeneration in Parkinson's disease: A role for nitric oxide. Ann NY Acad Sci 1994;738:64-68.
54. Ch'ng JLC, Shoemaker DL, Schimmel P, Holmes EW: Reversal of creatine kinase translational repression by 3′ untranslated sequences. Science 1990;248:1003-1006.
55. Ch'ng JLC, Ibrahim B: Transcriptional and posttranscriptional mechanisms modulate creatine kinase expression during differentiation of osteoblastic cells. J Biol Chem 1994;269: 2336-2341.